Erythromelalgia: Review of clinical characteristics and pathophysiology

https://doi.org/10.1016/0002-9343(91)90160-YGet rights and content

Abstract

Erythromelalgia is characterized by burning discomfort, warmth, and dermal erythema of the feet and/or the hands. Lowering the involved part and exposure to heat worsen symptoms, whereas elevation or cooling of the extremity relieves the discomfort. Several different subtypes of erythromelalgia have been documented and include an adult-onset form secondary to myeloproliferative syndrome-related thrombocytosis and an early-onset form that appears in childhood or adolescence and is idiopathic. A disturbed platelet function affecting the microvasculature has been implicated in thrombocythemia-related erythromelalgia. Importantly, manifestations of erythromelalgia often precede the onset of the myeloproliferative disease by several years. Therefore, the blood cell count should be monitored periodically in all adult patients with erythromelalgia. An abnormal hemoglobin, white blood cell, or platelet count or the presence of immature cells in the differential should prompt the physician to initiate a diagnostic evaluation for an underlying hematologic disorder. The symptoms of adults with erythromelalgia are markedly relieved after treatment with a single daily dose of acetylsalicylic acid. In contrast, childhood erythromelalgia appears without an underlying disorder, may be familial, and is resistant to treatment with aspirin.

References (85)

  • AM Putt

    Erythromelalgia—a case for biofeedback

    Nurs Clin North Am

    (1978)
  • ED Telford et al.

    Erythromelalgia

    BMJ

    (1940)
  • DR Thomas

    Primary erythromelalgia associated with cerebral infarctions

    J Miss State Med Assoc

    (1985)
  • S Ozsoylu et al.

    Sodium nitroprusside treatment in erythromelalgia

    Eur J Pediatr

    (1984)
  • RM Turf et al.

    Causalgia: clarifications in terminology and a case presentation

    J Foot Surg

    (1986)
  • RR Babb et al.

    Erythermalgia: review of 51 cases

    Circulation

    (1964)
  • JJ Michiels et al.

    Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia

    Ann Intern Med

    (1985)
  • SW Mitchell

    On a rare vaso-motor neurosis of the extremities, and on the maladies with which it may be confounded

    Am J Med Sci

    (1878)
  • SW Mitchell

    Clinical lecture on certain painful affections of the feet

    Philadelphia Med Times

    (1872)
    SW Mitchell

    Clinical lecture on certain painful affections of the feet

    Philadelphia Med Times

    (1872)
  • R Cassirer

    Die vasomotorisch-trophischen Neurosen

  • E May et al.

    Erythromelalgia: etude de la pathologie du synpathique

    Ann de Ned

    (1924)
  • LA Smith et al.

    Erythermalgia (erythromelalgia) of the extremities: a syndrome characterized by redness, heat, and pain

    Am Heart J

    (1938)
  • JJ Michiels et al.

    Erythromelalgia without thrombocythemia

    Ann Intern Med

    (1985)
  • D Alarcon-Segovia

    Erythromelalgia without thrombocythemia

    Ann Intern Med

    (1985)
  • S Bloom

    Erythromelalgia

    N Y State J Med

    (1964)
  • EV Allen et al.

    Peripheral vascular diseases

  • K Kvernebo et al.

    Erythromelalgia—pathophysiological and therapeutic aspects: a preliminary report

    J Oslo City Hosp

    (1987)
  • R Kurzrock et al.

    Erythromelalgia and myeloproliferative disorders

    Arch Intern Med

    (1989)
  • D Alarcon-Segovia et al.

    Erythermalgia: a clue to the early diagnosis of myeloproliferative disorders

    Arch Intern Med

    (1966)
  • W Dameshek et al.

    The diagnosis of polycythemia

    Ann Intern Med

    (1940)
  • GE Brown et al.

    Peripheral arterial disease in polycythemia vera

    Arch Intern Med

    (1930)
  • KG Redding

    Thrombocythemia as a cause of erythermalgia

    Arch Dermatol

    (1977)
  • B Bornstein et al.

    Erythermalgia: a case report

    J Am Podiatr Assoc

    (1978)
  • IL Norman et al.

    The vascular complications of polycythemia

    Am Heart J

    (1937)
  • BS Oppenheimer

    Vascular occlusion in polycythemia vera

    Trans Acad Am Physicians

    (1929)
  • B Boneu et al.

    Abnormalities of platelet aggregation during essential thrombocythemia: effect of aspirin on erythromelalgia

    Nouv Presse Med

    (1972)
  • G Fitzgerald et al.

    Burning feet

    BMJ

    (1976)
  • RE Millard et al.

    Clinical manifestations of essential thrombocythemia in young adults

    Am J Hematol

    (1990)
  • JL Ratz et al.

    Erythermalgia with vasculitis: a review

    J Am Acad Dermatol

    (1979)
  • D Alarcon-Segovia et al.

    Erythermalgia in systemic lupus erythematosus

    Am J Med Sci

    (1973)
  • A Kraus

    Erythromelalgia in a patient with systemic lupus erythematosus treated with clonazepam

    J Rhematol

    (1990)
  • H Hammar

    Plantar lesions of lichen sclerosus et atrophicus accompanied by erythermalgia

    Acta Derm Venereol (Stockh)

    (1978)
  • Cited by (69)

    • Erythromelalgia: A Review of Medical Management Options and Our Approach to Management

      2023, Mayo Clinic Proceedings
      Citation Excerpt :

      For patients with EM who do not have contraindications to aspirin, a daily 325-mg dose should be administered for at least 1 month. Aspirin is especially effective in patients who have secondary EM due to underlying myeloproliferative disease, such as essential thrombocytosis and polycythemia vera; dramatic improvement has been reported to occur within days of aspirin initiation.21,22 The antiplatelet effects of aspirin make it particularly useful in this subset of patients.

    • Aspirin and its pleiotropic application

      2020, European Journal of Pharmacology
      Citation Excerpt :

      The dose of aspirin used ranges from 325 to 650 mg per day, with a 500 mg dose of aspirin lasting for 3 days. This long-lasting effect of aspirin can also be used in diagnostics for myeloproliferative disease-linked secondary erythromelalgia (Kurzrock and Cohen, 1991; Preston, 1983). Aspirin has also been suggested as a treatment in necrobiosis lipoidica diabeticorum - a rare skin condition associated with diabetes mellitus and characterized by degenerative and granulomatous changes (Reid et al., 2013).

    • Erythromelalgia

      2013, Vascular Medicine: A Companion to Braunwald's Heart Disease: Second Edition
    • Pediatric erythromelalgia: A retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period

      2012, Journal of the American Academy of Dermatology
      Citation Excerpt :

      The clinical presentation was consistent with that described in adult patients: during symptomatic periods, the affected areas were red, hot, and painful3; between these episodes, they were frequently cool, cyanotic, and mildly uncomfortable.15 Underlying disorders previously described in association with erythromelalgia2,3,5,16,17 were not present in this group of pediatric patients; in particular, none had myeloproliferative disease. Only one patient had hypertension.

    • Hurwitz Clinical Pediatric Dermatology, Fouth Edition

      2011, Hurwitz Clinical Pediatric Dermatology, Fouth Edition
    • Thrombohemorrhagic complications of myeloproliferative disorders

      2010, Blood Reviews
      Citation Excerpt :

      Administration of aspirin or NSAID typically results in alleviation of the symptoms,30–32 though in some cases platelet-pheresis or cytoreduction is needed. Erythromelalgia, although not restricted to MPD,33 raises a high suspicion for an MPD, since it has never been observed in secondary thrombocytosis, suggesting that the major pathogenetic role for the phenomenon is associated with qualitative platelet abnormalities.34 Bleeding in MPD is less frequent and clinically grave than thrombosis, and it is more common in ET patients with high platelet counts.35

    View all citing articles on Scopus
    View full text